The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNBLS.L Regulatory News (NBLS)

  • There is currently no data for NBLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: Analysis of proposals

5 Aug 2020 15:13

RNS Number : 2681V
NB Global Floating Rate Income Fund
05 August 2020
 

NB Global Floating Rate Income Fund: Analysis of proposals 

05/08/2020

The board of the £335m NB Global Floating Rate Income Fund revealed plans today to adopt a new approach with a revised investment objective allowing the managers to invest in a much broader range of assets, including alternative credit, and to pay income on a monthly basis; the latter commencing after the declaration of the 2020 Q3 dividend.

The new investment objective will mean the trust can still invest in 'senior secured, floating rate' loans (which have their 'coupon' tied to interest rates and therefore should cope better in a rising rate environment than conventional fixed rate bonds) where the majority of its portfolio is currently held, but will also be able to invest in a broad range of other debt types including but not limited to high yield and investment grade bonds and alternative credit comprising of distressed credit type situations , mezzanine debt and - importantly, as we discuss later - private corporate loans.

The proposals, which are subject to approval by shareholders at an EGM scheduled for September 8, will also see a tender offer allowing existing shareholders who wish to exit the trust - currently trading on a discount of 8% - to do so at a discount of 2%, with plans to accommodate up to 40% of the shares in issue.

Should the proposals be approved, the revamped trust will implement a discount control policy, effective 1st January 2021 allowing investors to tender their shares at a discount of 3% every six months, after an initial period of eighteen months following the adoption of the new policy.

 

Kepler View

The proposals which the board have put forward give the team at Neuberger Berman (NB) a considerably broader palette with which to work.

They turn what was a single strategy fund - the merit of which from an investor's point of view was highly sensitive to the direction of and speed at which interest rates were moving - into a far more flexible vehicle, designed to generate income via a broad portfolio of debt assets.

If shareholders vote to approve these proposals the trust will effectively become a strategic bond "best-ideas" fund with a very broad remit, which includes access to some assets - like private debt - that can't be bought in open-ended funds.

Given the size and expertise of the team at NB - the current management group sits within a larger team of 40 investment professionals and NB runs over $120bn of fixed income assets - this ability to invest in private transactions is particularly interesting...

 

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUPURURUPUGCA
Date   Source Headline
22nd Apr 20206:00 pmRNSNet Asset Value(s)
21st Apr 20206:00 pmRNSNet Asset Value(s)
20th Apr 20206:00 pmRNSNet Asset Value(s)
17th Apr 20206:00 pmRNSNet Asset Value(s)
17th Apr 20207:00 amRNSPortfolio Update - March 2020
16th Apr 20206:00 pmRNSNet Asset Value(s)
16th Apr 20205:30 pmRNSNotice of AGM
15th Apr 20206:00 pmRNSNet Asset Value(s)
14th Apr 20206:00 pmRNSNet Asset Value(s)
14th Apr 20202:30 pmRNSInvestor Call / Webinar
9th Apr 20206:00 pmRNSNet Asset Value(s)
9th Apr 20205:27 pmRNSDividend Declaration (Replacement)
9th Apr 20207:00 amRNSAnnual Financial Report
8th Apr 20206:00 pmRNSNet Asset Value(s)
8th Apr 20205:14 pmRNSDividend Declaration
7th Apr 20206:00 pmRNSNet Asset Value(s)
6th Apr 20206:00 pmRNSNet Asset Value(s)
3rd Apr 20206:00 pmRNSNet Asset Value(s)
2nd Apr 20206:00 pmRNSNet Asset Value(s)
1st Apr 20206:00 pmRNSNet Asset Value(s)
1st Apr 20208:06 amRNSTotal Voting Rights
30th Mar 20206:00 pmRNSNet Asset Value(s)
27th Mar 20206:00 pmRNSNet Asset Value(s)
26th Mar 20206:00 pmRNSNet Asset Value(s)
25th Mar 20206:00 pmRNSNet Asset Value(s)
24th Mar 20206:00 pmRNSNet Asset Value(s)
24th Mar 20201:00 pmRNSDelay of Audited 2019 Annual Report
24th Mar 20207:00 amRNSTransaction in Own Shares
23rd Mar 20206:00 pmRNSNet Asset Value(s)
20th Mar 20206:00 pmRNSNet Asset Value(s)
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20206:00 pmRNSNet Asset Value(s)
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20206:30 pmRNSNet Asset Value(s)
18th Mar 20207:00 amRNSTransaction in Own Shares
17th Mar 20206:00 pmRNSNet Asset Value(s)
16th Mar 20206:00 pmRNSNet Asset Value(s)
13th Mar 20206:00 pmRNSNet Asset Value(s)
13th Mar 20205:20 pmRNSHolding(s) in Company
13th Mar 20207:00 amRNSPortfolio Update - Feb 2020
12th Mar 20206:00 pmRNSNet Asset Value(s)
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20206:00 pmRNSNet Asset Value(s)
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20206:00 pmRNSNet Asset Value(s)
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20206:00 pmRNSNet Asset Value(s)
9th Mar 20207:00 amRNSTransaction in Own Shares
6th Mar 20206:00 pmRNSNet Asset Value(s)
6th Mar 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.